C
Creverse Inc
KOSDAQ:096240
Creverse Inc
KOSDAQ:096240
Price:
14 790
KRW
-2.38%
Market Closed
Market Cap:
164.8B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Creverse Inc
14790
-360 (-2.38%)
| 52 Week Range |
14 700
19 360
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Creverse Inc
Balance Sheet
Balance Sheet Decomposition
Creverse Inc
Creverse Inc
| Current Assets | 43.5B |
| Cash & Short-Term Investments | 28B |
| Receivables | 11.9B |
| Other Current Assets | 3.5B |
| Non-Current Assets | 150.9B |
| Long-Term Investments | 36.7B |
| PP&E | 66.8B |
| Intangibles | 39.4B |
| Other Non-Current Assets | 8B |
| Current Liabilities | 123.7B |
| Accounts Payable | 179.9m |
| Short-Term Debt | 76.6B |
| Other Current Liabilities | 46.9B |
| Non-Current Liabilities | 34B |
| Long-Term Debt | 181m |
| Other Non-Current Liabilities | 33.8B |
Balance Sheet
Creverse Inc
Creverse Inc
Currency: KRW
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
18 731
|
12 970
|
18 279
|
14 505
|
12 832
|
19 218
|
29 412
|
52 332
|
55 189
|
29 692
|
|
| Cash |
5
|
16
|
0
|
1
|
2
|
4
|
1
|
5
|
0
|
0
|
|
| Cash Equivalents |
18 726
|
12 954
|
18 279
|
14 504
|
12 830
|
19 214
|
29 411
|
52 327
|
55 189
|
29 692
|
|
| Short-Term Investments |
8 126
|
563
|
7 689
|
13 247
|
5 712
|
3 867
|
1 108
|
2 201
|
2 094
|
3 695
|
|
| Total Receivables |
22 288
|
23 787
|
20 859
|
22 347
|
20 640
|
18 961
|
17 404
|
17 030
|
14 098
|
15 490
|
|
| Accounts Receivables |
21 292
|
21 483
|
20 508
|
19 291
|
17 695
|
15 911
|
16 059
|
15 321
|
13 153
|
13 367
|
|
| Other Receivables |
996
|
2 304
|
351
|
3 056
|
2 945
|
3 050
|
1 345
|
1 709
|
945
|
2 123
|
|
| Inventory |
1 339
|
1 601
|
1 835
|
2 106
|
2 268
|
2 151
|
2 034
|
1 520
|
1 568
|
1 446
|
|
| Other Current Assets |
2 166
|
1 243
|
1 127
|
1 938
|
1 706
|
1 703
|
8 269
|
7 542
|
10 351
|
10 139
|
|
| Total Current Assets |
52 650
|
40 164
|
49 788
|
54 143
|
43 158
|
45 900
|
58 226
|
80 626
|
83 300
|
60 463
|
|
| PP&E Net |
10 860
|
15 021
|
12 381
|
36 869
|
27 465
|
53 853
|
84 681
|
81 099
|
93 409
|
79 203
|
|
| PP&E Gross |
10 860
|
15 021
|
0
|
36 869
|
27 465
|
53 853
|
84 681
|
81 099
|
93 409
|
79 203
|
|
| Accumulated Depreciation |
17 063
|
24 026
|
0
|
38 212
|
40 624
|
43 790
|
36 859
|
43 095
|
49 917
|
32 917
|
|
| Intangible Assets |
13 501
|
16 368
|
36 709
|
11 521
|
6 589
|
4 292
|
3 116
|
3 726
|
6 578
|
8 014
|
|
| Goodwill |
17 273
|
22 685
|
0
|
20 262
|
17 113
|
15 199
|
12 300
|
12 300
|
11 636
|
28 853
|
|
| Note Receivable |
528
|
340
|
1 002
|
1 829
|
1 896
|
1 726
|
1 177
|
97
|
29
|
268
|
|
| Long-Term Investments |
11 093
|
10 049
|
22 284
|
4 790
|
26 014
|
23 550
|
12 552
|
9 893
|
9 825
|
21 972
|
|
| Other Long-Term Assets |
16 017
|
16 179
|
3 217
|
19 774
|
23 370
|
21 789
|
21 338
|
21 875
|
25 085
|
25 377
|
|
| Other Assets |
17 273
|
22 685
|
0
|
20 262
|
17 113
|
15 199
|
12 300
|
12 300
|
11 636
|
28 853
|
|
| Total Assets |
121 921
N/A
|
120 806
-1%
|
125 382
+4%
|
149 188
+19%
|
145 607
-2%
|
166 309
+14%
|
193 391
+16%
|
209 615
+8%
|
229 861
+10%
|
224 150
-2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
452
|
127
|
159
|
253
|
172
|
155
|
153
|
162
|
88
|
247
|
|
| Short-Term Debt |
10 219
|
22 856
|
26 205
|
33 240
|
25 946
|
42 125
|
40 780
|
38 030
|
32 050
|
61 380
|
|
| Current Portion of Long-Term Debt |
82
|
0
|
0
|
0
|
3 094
|
0
|
8 946
|
10 427
|
13 055
|
13 887
|
|
| Other Current Liabilities |
21 766
|
36 624
|
37 510
|
23 766
|
20 730
|
23 714
|
30 757
|
28 880
|
35 449
|
33 541
|
|
| Total Current Liabilities |
32 520
|
59 607
|
63 874
|
57 259
|
49 941
|
65 994
|
80 636
|
77 500
|
80 643
|
109 055
|
|
| Long-Term Debt |
13 896
|
0
|
1 777
|
5 801
|
5 800
|
2 750
|
11 728
|
11 251
|
28 305
|
46 536
|
|
| Minority Interest |
1 353
|
3 429
|
6 047
|
21 098
|
23 842
|
23 046
|
21 763
|
22 905
|
20 033
|
1 652
|
|
| Other Liabilities |
8 134
|
2 517
|
4 018
|
6 865
|
6 207
|
8 319
|
13 502
|
17 519
|
17 876
|
21 645
|
|
| Total Liabilities |
55 903
N/A
|
65 553
+17%
|
75 716
+16%
|
91 023
+20%
|
85 791
-6%
|
100 109
+17%
|
127 629
+27%
|
129 175
+1%
|
146 857
+14%
|
178 888
+22%
|
|
| Equity | |||||||||||
| Common Stock |
3 107
|
3 107
|
3 111
|
3 448
|
3 519
|
3 837
|
3 837
|
3 837
|
3 862
|
5 872
|
|
| Retained Earnings |
43 380
|
43 908
|
37 754
|
12 707
|
10 394
|
10 583
|
11 036
|
9 833
|
13 618
|
98 123
|
|
| Additional Paid In Capital |
41 847
|
41 948
|
39 170
|
46 472
|
50 814
|
57 916
|
58 760
|
59 867
|
59 346
|
14 284
|
|
| Unrealized Security Profit/Loss |
219
|
24
|
0
|
0
|
1 722
|
624
|
1 085
|
1 752
|
1 307
|
2 560
|
|
| Treasury Stock |
12 452
|
13 456
|
0
|
0
|
12 902
|
12 902
|
12 902
|
0
|
1 305
|
79 407
|
|
| Other Equity |
10 083
|
20 228
|
30 369
|
4 462
|
6 268
|
6 143
|
6 115
|
8 655
|
8 790
|
8 949
|
|
| Total Equity |
66 018
N/A
|
55 253
-16%
|
49 666
-10%
|
58 165
+17%
|
59 816
+3%
|
66 201
+11%
|
65 762
-1%
|
80 441
+22%
|
83 004
+3%
|
45 262
-45%
|
|
| Total Liabilities & Equity |
121 921
N/A
|
120 806
-1%
|
125 382
+4%
|
149 188
+19%
|
145 607
-2%
|
166 309
+14%
|
193 391
+16%
|
209 615
+8%
|
229 861
+10%
|
224 150
-2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
5
|
5
|
5
|
6
|
6
|
7
|
7
|
7
|
8
|
8
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
